Skip to main content

Profiles

AIM at Melanoma Foundation

The AIM at Melanoma Foundation is an American nonprofit organization based in Frisco, Texas.

History

In the first quarter of 2021, the foundation received a $10,000 grant from Pfizer for a project titled “From the Clinic to the Living Room.”[1]

Organization

AIM at Melanoma is a partner of the Society for Immunotherapy of Cancer.[2]

Sponsors

The foundation is sponsored by:[3]

  • Alkermes
  • Amgen
  • BioAlta
  • BioNTech
  • Bristol-Myers Squibb (BMS)
  • Caris Life Sciences
  • Castle Biosciences
  • Checkmate Pharmaceuticals
  • Genentech
  • Immunocore
  • InstilBio
  • IO Biotech
  • Iovance Biotherapeutics
  • Istari
  • Merck
  • Myriad Genetics
  • Natera
  • Novartis
  • Oncosec Immunotherapies
  • Pfizer
  • Pierre Fabre
  • Regeneron Pharmaceuticals
  • Replimune
  • Roche
  • Sanofi Genzyme

  1. US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021. (2021, September 27). Pfizer. https://web.archive.org/web/20230503211316/https://s3.documentcloud.org/documents/23787007/pfizer-2021-report.pdf ↩︎

  2. Cancer Immunotherapy Partnerships and Collaborations. Society for Immunotherapy of Cancer. Retrieved March 27, 2023, from https://web.archive.org/web/20230327191240/https://www.sitcancer.org/aboutsitc/partnerships#champions ↩︎

  3. Our Industry Partners. AIM at Melanoma Foundation. Retrieved May 10, 2023, from https://web.archive.org/web/20230510200316/https://www.aimatmelanoma.org/our-industry-partners/ ↩︎